NO20055986L - Forbindelse for behandling og forebygging av virale infeksjonssykdommer - Google Patents

Forbindelse for behandling og forebygging av virale infeksjonssykdommer

Info

Publication number
NO20055986L
NO20055986L NO20055986A NO20055986A NO20055986L NO 20055986 L NO20055986 L NO 20055986L NO 20055986 A NO20055986 A NO 20055986A NO 20055986 A NO20055986 A NO 20055986A NO 20055986 L NO20055986 L NO 20055986L
Authority
NO
Norway
Prior art keywords
compound
infectious diseases
viral infectious
prevention
same
Prior art date
Application number
NO20055986A
Other languages
English (en)
Norwegian (no)
Inventor
Takuo Tsukuda
Takeshi Murata
Masayuki Sudoh
Miyako Masubuchi
Kenichi Kawasaki
Fumio Watanabe
Hiroshi Fukuda
Susumu Komiyama
Tadakatsu Hayase
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO20055986L publication Critical patent/NO20055986L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO20055986A 2003-07-09 2005-12-16 Forbindelse for behandling og forebygging av virale infeksjonssykdommer NO20055986L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003272420 2003-07-09
PCT/JP2004/009803 WO2005005372A1 (ja) 2003-07-09 2004-07-09 抗ｈｃｖ作用を有する化合物およびその製法

Publications (1)

Publication Number Publication Date
NO20055986L true NO20055986L (no) 2006-02-13

Family

ID=34055974

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055986A NO20055986L (no) 2003-07-09 2005-12-16 Forbindelse for behandling og forebygging av virale infeksjonssykdommer

Country Status (17)

Country Link
US (1) US7378446B2 (pt)
EP (1) EP1661882B1 (pt)
JP (1) JP4068639B2 (pt)
KR (1) KR20060029182A (pt)
CN (1) CN1819990B (pt)
AU (1) AU2004255633B2 (pt)
BR (1) BRPI0412459A (pt)
CA (1) CA2531790A1 (pt)
IL (1) IL172666A0 (pt)
MX (1) MXPA06000294A (pt)
MY (1) MY143775A (pt)
NO (1) NO20055986L (pt)
NZ (1) NZ545102A (pt)
RU (1) RU2346933C2 (pt)
TW (1) TWI330173B (pt)
UA (1) UA92134C2 (pt)
WO (1) WO2005005372A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795206A4 (en) * 2004-08-11 2009-07-22 Chugai Pharmaceutical Co Ltd MEDICAMENT FOR THE TREATMENT OR PREVENTION OF HCV INFECTION
JP2006077004A (ja) * 2004-08-11 2006-03-23 Chugai Pharmaceut Co Ltd 抗ｈｃｖ作用を有する化合物およびそれを含む医薬組成物
US7897783B2 (en) * 2005-02-17 2011-03-01 Chugai Seiyaku Kabushiki Kaisha Intermediate compound for synthesis of viridiofungin a derivative
US20110098477A1 (en) * 2005-06-28 2011-04-28 Chugai Seiyaku Kabushiki Kaisha Method Of Producing Compound Having Anti-Hcv Activity
EP1957476A1 (en) * 2005-11-23 2008-08-20 AstraZeneca AB L-alanine derivatives
EP2042188A4 (en) 2006-05-16 2011-11-16 Tokyo Metropolitan Org Med Res PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF HCV INFECTION
US20080045521A1 (en) * 2006-06-09 2008-02-21 Astrazeneca Ab Phenylalanine derivatives
WO2008093065A1 (en) * 2007-01-29 2008-08-07 Astrazeneca Ab L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS
WO2008125811A1 (en) * 2007-04-11 2008-10-23 Astrazeneca Ab N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
TW201010692A (en) * 2008-06-19 2010-03-16 Public Univ Corp Nagoya City Univ Pharmaceutical composition for treatment or prevention of hbv infection
EP2610343A3 (en) 2008-11-26 2013-09-25 Chugai Seiyaku Kabushiki Kaisha Method for designing siRNA and oligoribonucleotides inhibiting HCV
JP2013121935A (ja) 2011-12-12 2013-06-20 Institute Of Microbial Chemistry 化合物、及び不斉合成反応
WO2014027696A1 (ja) 2012-08-17 2014-02-20 中外製薬株式会社 抗ｈｃｖ作用を有する経口投与可能なビリジオファンジン誘導体
WO2021039175A1 (ja) * 2019-08-23 2021-03-04 パナソニック株式会社 支援装置、生成装置、分析装置、支援方法、生成方法、分析方法、およびプログラム

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364948A (en) 1991-08-02 1994-11-15 Merck & Co., Inc. Biologically active compounds isolated from aerobic fermentation of Trichoderma viride
EP0526936A3 (en) 1991-08-02 1993-05-05 Merck & Co. Inc. Cholesterol-lowering agents
US5503973A (en) 1992-05-29 1996-04-02 The Regents Of The University Of California Method for inhibition of viral morphogenesis
DE4415312A1 (de) * 1994-05-02 1995-11-09 Hoechst Ag Verfahren zur Herstellung von N-Acylglycinderivaten
EP1002793B1 (en) * 1997-06-09 2003-09-24 Takara Bio Inc. Physiologically active substances tkr2449, process for producing the same, and microorganism
JP5025051B2 (ja) 2001-07-26 2012-09-12 サトーホールディングス株式会社 印字編集処理装置
JP4093534B2 (ja) 2002-03-15 2008-06-04 スタンレー電気株式会社 車両用前照灯
MY141506A (en) 2003-02-12 2010-05-14 Chugai Pharmaceutical Co Ltd Virus therapeutic drug

Also Published As

Publication number Publication date
MY143775A (en) 2011-07-15
CN1819990B (zh) 2010-04-21
IL172666A0 (en) 2006-04-10
UA92134C2 (ru) 2010-10-11
TWI330173B (en) 2010-09-11
MXPA06000294A (es) 2006-04-18
WO2005005372A1 (ja) 2005-01-20
TW200524847A (en) 2005-08-01
US20060194870A1 (en) 2006-08-31
CN1819990A (zh) 2006-08-16
US7378446B2 (en) 2008-05-27
EP1661882B1 (en) 2013-10-30
RU2006103803A (ru) 2006-08-10
CA2531790A1 (en) 2005-01-20
HK1093485A1 (zh) 2007-03-02
RU2346933C2 (ru) 2009-02-20
AU2004255633A1 (en) 2005-01-20
NZ545102A (en) 2008-11-28
AU2004255633B2 (en) 2009-08-06
EP1661882A4 (en) 2007-01-31
BRPI0412459A (pt) 2006-10-17
EP1661882A1 (en) 2006-05-31
JP4068639B2 (ja) 2008-03-26
JPWO2005005372A1 (ja) 2006-08-24
KR20060029182A (ko) 2006-04-04

Similar Documents

Publication Publication Date Title
NO20062339L (no) Hepatitt C virus-inhibitoerer
NO20044807L (no) Heratitt C virus inhibitorer
WO2003015798A1 (fr) Nouvelle methode virocide/inhibitrice de la proliferation virale et nouvel analogue de pyradine nucleotide/pyradine nucleoside
WO2006039488A3 (en) Hcv ns3-ns4a protease inhibition
WO2006027628A3 (en) Naphthalimide derivatives as antiviral agents
HUP0101137A2 (hu) Véralvadást gátló savamidin-származékok és gyógyászati alkalmazásuk
NO20062267L (no) Hepatitt C virus inhibitorer
NO20082934L (no) Antivirale nukleotider
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
MY146669A (en) Pyrazole derivatives for treating hiv
DK1940786T3 (da) Biphenylderivater og deres anvendelse ved behandling af hepatitis C
WO2005084192A3 (en) Novel 2’-c-methyl nucleoside derivatives
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CY1113038T1 (el) Τριετεροκυκλικες ενωσεις, συνθεσεις, και μεθοδοι για τη θεραπεια καρκινου
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
WO2004087699A3 (en) Thiazoles useful as inhibitors of protein kinases
WO2004087698A3 (en) Thiazoles useful as inhibitors of protein kinases
NO20091704L (no) Inhibitorer av hepatitt C virus
EA200701504A1 (ru) Индолы, пригодные для лечения воспалений
JP2005539088A5 (pt)
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
WO2023154519A8 (en) Inhibitors of rna helicase dhx9 and uses thereof
NO983991L (no) Serin-protease-inhibitorer
TW200508218A (en) Inhibitors of papilloma virus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application